510(k) K252336
K252336 is an FDA 510(k) premarket notification submitted by Diazyme Laboratories, Inc. for the device "Diazyme Immunoglobulin A Assay; Diazyme Immunoglobulin G Assay; Diazyme Immunoglobulin M Assay". The FDA issued a decision of Substantially Equivalent on April 24, 2026. Diazyme Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 24, 2026
- Date Received
- July 28, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No